Biosimilars: New Avenues for the Practicing Oncologist Treating Breast Cancer

Research presented this week at ESMO studied the efficacy of  biosimilars to trastuzumab compared with the reference product in breast cancer.

Source: CancerNetwork - October 26, 2018 Category: Cancer & Oncology Authors: Traci DeVito Source Type: news